OpenSourceMalaria:Compound Series: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Matthew Todd (talk | contribs) mNo edit summary |
Anthony Sama (talk | contribs) No edit summary |
||
| (13 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{OpenSourceMalaria}} | {{OpenSourceMalaria}} | ||
[[OpenSourceMalaria: | A summary of progress in the OSM project may be found in the [[OpenSourceMalaria:Story_so_far|Story so Far]]. The pages below include the technical detail of the individual series examined and are written for scientific contributors. | ||
[[OpenSourceMalaria: | [[OpenSourceMalaria:GSK_Arylpyrrole_Series |'''Series 1: GSK Arylpyrroles''']] (Paper has been released: http://pubs.acs.org/doi/full/10.1021/acscentsci.6b00086) | ||
[[OpenSourceMalaria: | [[OpenSourceMalaria:GSK_Triazolourea_Singleton |'''Series 2: GSK Triazoloureas''']] (parked) | ||
[[OpenSourceMalaria:Triazolopyrazine_(TP)_Series |'''Series 4: Triazolopyrazines ( | [[OpenSourceMalaria:GSK_Amino-thienopyrimidine_Series |'''Series 3: GSK Thienopyrimidines''']] (work is resuming) | ||
[[OpenSourceMalaria:Triazolopyrazine_(TP)_Series |'''Series 4: Triazolopyrazines (TP series)''']] (current priority) | |||
[[OpenSourceMalaria:Triazolopyrazine_Series Mechanism of Action |'''Series 4: Mechanism of Action''']] | |||
[[OpenSourceMalaria:Synthesis Branches |'''Synthetic Branches''']] | |||
[[OpenSourceMalaria:Obtaining Compounds for OSM |'''Obtaining Compounds for OSM''']] | |||
[[OpenSourceMalaria:Repurposing |'''Repurposing''']] | |||
[[OpenSourceMalaria:Other_GSK_Series_Under_Consideration |'''Other Possible GSK Series''']] | [[OpenSourceMalaria:Other_GSK_Series_Under_Consideration |'''Other Possible GSK Series''']] | ||
[[OpenSourceMalaria:Other Possible Series and Targets | '''Other Possible Series and Targets''']] | |||
[[OpenSourceMalaria:Epigenetic Regulation of Life Cycle | '''Epigenetic Regulation of Lifecycle''']] | |||
Latest revision as of 11:24, 27 May 2017
A summary of progress in the OSM project may be found in the Story so Far. The pages below include the technical detail of the individual series examined and are written for scientific contributors.
Series 1: GSK Arylpyrroles (Paper has been released: http://pubs.acs.org/doi/full/10.1021/acscentsci.6b00086)
Series 2: GSK Triazoloureas (parked)
Series 3: GSK Thienopyrimidines (work is resuming)
Series 4: Triazolopyrazines (TP series) (current priority)
